Add to ORKGBackground Bimatoprost 0.03 % has enhanced eyelash prominence in clinical trials enrolling mostly Caucasian subjects. The studies described in this report evaluated the efficacy and safety of bimatoprost in Japanese subjects with idiopathic and chemotherapy-induced eyelash hypotrichosis. Methods In two multicenter, double-masked, randomized, parallel-group studies (study 1: n = 173 [idiopathic]; stud
In Japan, academic clinical trials do not generally need to be conducted under good clinical practic...
Purpose: To test the efficacy of bimatoprost 0.03% 2D for lowering intraocular pressure (IOP) in pat...
their evaluation is critical for the success of hematopoietic stem cell transplantation (HST) in Cau...
BACKGROUND: Bimatoprost ophthalmic solution 0.03% is approved in several countries for treating eyel...
Mark Borchert,1 Suzanne Bruce,2 David Wirta,3 Steven G Yoelin,4 Sungwook Lee,5 Cheri Mao,5 Amanda Va...
PURPOSE: To investigate the efficacy of reducing the drop-skin contact to prevent dermatologic side ...
OBJECTIVE: The objective of this systematic review is to determine whether or not bimatoprost 0.03% ...
Tomoaki Higashiyama, Masahito Ohji Department of Ophthalmology, Shiga University of Medical Science...
Steven FagienAesthetic Eyelid Plastic Surgery, Boca Raton, FL, USAAbstract: Prominent eyelashes are ...
Purpose: To investigate the topical use of travoprost [Trademark: Travatan (Alcon laboratories Inc, ...
In December 2008, bimatoprost ophthalmic solution 0.03% was approved in the United States for the tr...
Purpose: To determine the effect of upper eyelid platinum chain implantation, with the pretarsal fix...
Objective: Tamsulosin is often administered at a dose of 0.2 mg in Japan, Korea, and elsewhere in As...
Purpose: To assess the efficacy and safety of switching patients from bilateral latanoprost to bimat...
Nongsak Chanasumon, Tueboon Sriphojanart, Poonkiat Suchonwanit Division of Dermatology, Department ...
In Japan, academic clinical trials do not generally need to be conducted under good clinical practic...
Purpose: To test the efficacy of bimatoprost 0.03% 2D for lowering intraocular pressure (IOP) in pat...
their evaluation is critical for the success of hematopoietic stem cell transplantation (HST) in Cau...
BACKGROUND: Bimatoprost ophthalmic solution 0.03% is approved in several countries for treating eyel...
Mark Borchert,1 Suzanne Bruce,2 David Wirta,3 Steven G Yoelin,4 Sungwook Lee,5 Cheri Mao,5 Amanda Va...
PURPOSE: To investigate the efficacy of reducing the drop-skin contact to prevent dermatologic side ...
OBJECTIVE: The objective of this systematic review is to determine whether or not bimatoprost 0.03% ...
Tomoaki Higashiyama, Masahito Ohji Department of Ophthalmology, Shiga University of Medical Science...
Steven FagienAesthetic Eyelid Plastic Surgery, Boca Raton, FL, USAAbstract: Prominent eyelashes are ...
Purpose: To investigate the topical use of travoprost [Trademark: Travatan (Alcon laboratories Inc, ...
In December 2008, bimatoprost ophthalmic solution 0.03% was approved in the United States for the tr...
Purpose: To determine the effect of upper eyelid platinum chain implantation, with the pretarsal fix...
Objective: Tamsulosin is often administered at a dose of 0.2 mg in Japan, Korea, and elsewhere in As...
Purpose: To assess the efficacy and safety of switching patients from bilateral latanoprost to bimat...
Nongsak Chanasumon, Tueboon Sriphojanart, Poonkiat Suchonwanit Division of Dermatology, Department ...
In Japan, academic clinical trials do not generally need to be conducted under good clinical practic...
Purpose: To test the efficacy of bimatoprost 0.03% 2D for lowering intraocular pressure (IOP) in pat...
their evaluation is critical for the success of hematopoietic stem cell transplantation (HST) in Cau...